Search research articles
Contact Us
Filters
Showing results (11-20 of 163) with videos related to
Page
of 17
Sort By:
ACS Central Science
|
July 31, 2023
Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
SLAS Discovery : Advancing Life Sciences R & D
|
November 4, 2020
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida, Alessio Ciulli
Current Opinion in Biotechnology
|
October 26, 2007
Fragment-based approaches to enzyme inhibition
Alessio Ciulli, Chris Abell
Current Opinion in Structural Biology
|
August 21, 2024
Editorial overview: New concept in drug discovery
Andrea Cavalli, Alessio Ciulli
Future Medicinal Chemistry
|
May 20, 2016
Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology
Carles Galdeano, Alessio Ciulli
Current Opinion in Structural Biology
|
December 3, 2020
Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues
Sarath Ramachandran, Alessio Ciulli
Annual Review of Biochemistry
|
March 23, 2022
Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory
Angus D Cowan, Alessio Ciulli
Current Opinion in Chemical Biology
|
June 12, 2021
Editorial overview: Hot targets and new modalities
Alessio Ciulli, Ingrid E Wertz
Essays in Biochemistry
|
November 10, 2017
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
Scott J Hughes, Alessio Ciulli
Chemical Society Reviews
|
August 19, 2022
Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
Claudia J Diehl, Alessio Ciulli
Page
of 17
Search research articles
Search
Showing results (11-20 of 163) with videos related to
Sort By:
Page
of 17
ACS Central Science
|
July 31, 2023
Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
SLAS Discovery : Advancing Life Sciences R & D
|
November 4, 2020
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida, Alessio Ciulli
Current Opinion in Biotechnology
|
October 26, 2007
Fragment-based approaches to enzyme inhibition
Alessio Ciulli, Chris Abell
Current Opinion in Structural Biology
|
August 21, 2024
Editorial overview: New concept in drug discovery
Andrea Cavalli, Alessio Ciulli
Future Medicinal Chemistry
|
May 20, 2016
Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology
Carles Galdeano, Alessio Ciulli
Current Opinion in Structural Biology
|
December 3, 2020
Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues
Sarath Ramachandran, Alessio Ciulli
Annual Review of Biochemistry
|
March 23, 2022
Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory
Angus D Cowan, Alessio Ciulli
Current Opinion in Chemical Biology
|
June 12, 2021
Editorial overview: Hot targets and new modalities
Alessio Ciulli, Ingrid E Wertz
Essays in Biochemistry
|
November 10, 2017
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
Scott J Hughes, Alessio Ciulli
Chemical Society Reviews
|
August 19, 2022
Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
Claudia J Diehl, Alessio Ciulli
Page
of 17